Vinay Prasad has stepped down as head of the FDA's Center for Biologics Evaluation and Research (CBER), less than three months after taking on the role. His departure – first reported by STAT and now ...
Top priorities at the FDA in the coming years will include shorter review timelines for drug development, embracing the use of artificial intelligence and big data, and speeding up approvals for ...
WASHINGTON, DC – Dr. Vinay Prasad, the polarizing official who led U.S. vaccine oversight under the Trump administration, has stepped down from his position at the Food and Drug Administration (FDA) ...
TIOBE Index for January 2026: Top 10 Most Popular Programming Languages Your email has been sent January’s TIOBE Index begins the year with familiar names still setting the pace, but the underlying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback